Kazia Therapeutics LTD 6-K Filing
Ticker: KZIA · Form: 6-K · Filed: Nov 18, 2025 · CIK: 1075880
| Field | Detail |
|---|---|
| Company | Kazia Therapeutics LTD (KZIA) |
| Form Type | 6-K |
| Filed Date | Nov 18, 2025 |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $35 million |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 6-K filing submitted by Kazia Therapeutics LTD (ticker: KZIA) to the SEC on Nov 18, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $35 million (ities ("MVLS") was below the minimum of $35 million required for continued listing on The N).
How long is this filing?
Kazia Therapeutics LTD's 6-K filing is 3 pages with approximately 761 words. Estimated reading time is 3 minutes.
Where can I view the full 6-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 761 words · 3 min read · ~3 pages · Grade level 19.6 · Accepted 2025-11-18 16:14:30
Key Financial Figures
- $35 million — ities ("MVLS") was below the minimum of $35 million required for continued listing on The N
Filing Documents
- d24645d6k.htm (6-K) — 12KB
- 0001193125-25-286169.txt ( ) — 13KB
Forward-Looking Statements
Forward-Looking Statements This report of foreign private issuer on Form 6-K may contain forward-looking statements, which can generally be identified as such by the use of words such as "may," "will," "estimate," "future," "forward," "anticipate," or other similar words. Any statement describing Kazia's future plans, strategies, intentions, expectations, objectives, goals or prospects, and other statements that are not historical facts, are also forward looking statements, including, but not limited to, statements regarding: Kazia's intent to demonstrate its ability to regain compliance with the MVLS requirement, the outcome of the Panet's review of any Kazia appeal of the Staff's determination, and any course of action to regain compliance with the Nasdaq continued listing requirements. Such statements are based on Kazia's current expectations and projections about future events and future trends affecting its business and are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements, including risks and uncertainties associated with Kazia's ability to regain and/or maintain compliance with the applicable Nasdaq continued listing requirements and standards. These and other risks and uncertainties are described more fully in Kazia's Annual Report, filed on Form 20-F with the SEC on November 7, 2025, and in subsequent filings with the United States Securities and Exchange Commission. Kazia undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required under applicable law. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this report of foreign private issuer on Form 6-K. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its